You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 20, November 11, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Osteoporosis
 •Women's Health
 •Menopause
 •Alert me on articles by topic

Osteoporosis and Fractures in Postmenopausal Women Using Estrogen

Heidi D. Nelson, MD, MPH; Joanne Rizzo, MA; Emily Harris, PhD; Jane Cauley, DrPH; Kristine Ensrud, MD, MPH; Douglas C. Bauer, MD; Eric Orwoll, MD; for the Study of Osteoporotic Fractures Research Group

Arch Intern Med. 2002;162:2278-2284.

Background  Previous studies demonstrate that postmenopausal women who use estrogen are somewhat protected from bone loss and fractures compared with nonusers, but the extent to which estrogen users remain at risk for osteoporosis and fractures is uncertain.

Objective  To determine long-term probabilities for incident fractures among postmenopausal estrogen users.

Methods  We examined data from the Study of Osteoporotic Fractures, a prospective cohort study with 10 years of follow-up (1986-1999). This cohort includes 8816 women 65 years and older from community settings in 4 areas of the United States.

Main Outcome Measures  Hip, wrist, vertebral, and nonvertebral fractures.

Results  At baseline, using criteria developed by the World Health Organization, 40% of continuous estrogen users were osteopenic and 13% were osteoporotic at the hip or spine. Although women currently using estrogen lost less bone density than past users or those who never used estrogen, all user groups on average lost bone from the hip and calcaneus. During 10 years of observation, the adjusted probability of nonvertebral fractures was 19.6% for continuous estrogen users, similar to current partial users and lower than past users and those who never used estrogen (P<.05). These comparisons were similar for hip, wrist, and vertebral fractures.

Conclusions  Although estrogen use is associated with reduced prevalence of low bone density, less bone loss, and lower probabilities for fractures, osteoporosis and fractures are common in older women who used estrogen continuously since menopause. Estrogen users should be considered in strategies designed to detect, prevent, and treat osteoporosis.


From the Departments of Medical Informatics and Outcomes Research (Dr Nelson) and Medicine (Drs Nelson and Orwoll), Oregon Health and Science University, Portland; the Medical Service, Veterans Affairs Medical Center, Portland (Dr Nelson); the Center for Health Research, Northwest Kaiser Permanente, Portland (Ms Rizzo and Dr Harris); the Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pa (Dr Cauley); the Department of Internal Medicine and Epidemiology, University of Minnesota, Minneapolis (Dr Ensrud); and the Department of Epidemiology and Biostatistics, University of California, San Francisco (Dr Bauer).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

As a Matter of Fat: New Perspectives on the Understanding of Age-Related Bone Loss
Duque
IBMS BoneKEy 2007;4:129-140.
ABSTRACT | FULL TEXT  

An AOA Critical Issue: Aging of the North American Population: New Challenges for Orthopaedics
Buckwalter et al.
JBJS 2003;85:748-758.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.